Juvise Pharmaceuticals
⚠️ Moderate Risk
FEI: 3010418163 • Villeurbanne, Rhone • FRANCE
FEI Number
3010418163
Location
Villeurbanne, Rhone
Country
FRANCEAddress
149 Bd De La Bataille De Stalingrad, , Villeurbanne, Rhone, France
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
Frequently Asked Questions
What is Juvise Pharmaceuticals's FDA import refusal history?
Juvise Pharmaceuticals (FEI: 3010418163) has 2 FDA import refusal record(s) in our database, spanning from 10/23/2013 to 10/23/2013.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Juvise Pharmaceuticals's FEI number is 3010418163.
What types of violations has Juvise Pharmaceuticals received?
Juvise Pharmaceuticals has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Juvise Pharmaceuticals come from?
All FDA import refusal data for Juvise Pharmaceuticals is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.